Administration af Doxagamma 4 mg depottabletter og dermed forbundne navne hos hypertensive patienter medfører en klinisk signifikant reduktion af blodtrykket som et resultat af en reduktion i den systemiske vaskulære modstand.
Administration of Doxagamma 4 mg prolonged release tablets and associated names in hypertensive patients causes a clinically significant reduction in blood pressure as a result of a reduction in systemic vascular resistance.